MetLife Investment Management’s Apyx Medical APYX Stock Holding History

MetLife Investment Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,314	Closed	-$120K	–	2861
2022 Q1	$120K	Buy	18,314 +6,649	+57%	+$65.5K	﹤0.01%	2593
2021 Q4	$150K	Hold	11,665	–	–	﹤0.01%	2237
2021 Q3	$162K	Buy	+11,665	New	+$123K	﹤0.01%	2215
2021 Q2	–	Sell	-14,882	Closed	-$144K	–	2439
2021 Q1	$144K	Buy	+14,882	New	+$149K	﹤0.01%	2202
2020 Q1	–	Sell	-18,201	Closed	-$154K	–	2247
2019 Q4	$154K	Hold	18,201	–	–	﹤0.01%	2120
2019 Q3	$123K	Buy	+18,201	New	+$129K	﹤0.01%	2214

Other funds holding APYX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

MetLife Investment Management's APYX Position: Q2 2022 in Review

MetLife Investment Management sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 18,314 shares — an estimated $120K sold.

MetLife Investment Management first reported a position in APYX in Q3 2019 and held it in 6 quarters. The position peaked at $162K in Q3 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

MetLife Investment Management reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
MetLife Investment Management sold 18,314 Apyx Medical shares in Q2 2022, an estimated $120K.
MetLife Investment Management first reported a position in Apyx Medical in Q3 2019 and held it in 6 quarters.
MetLife Investment Management's Apyx Medical position peaked at $162K in Q3 2021.
63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on MetLife Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.